Send Enquiry

CURE
Tablets
Packaging and packing Type
Alu Alu | 10x10
MRP :
₹95
PTR :
₹72.38
PTS :
₹65.14
Prescription medicine Read More
Composition
Send Enquiry
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Repavib 0.5 is a tablet made by Vibcare Pharma. Each tablet contains Repaglinide 0.5 mg, which belongs to the glinide class of anti-diabetic medicines. It is packed as 10x10 (Alu Alu).
Repaglinide 0.5 mg works by prompting the pancreas to release insulin, which helps move glucose from the blood into the body's cells. This action depends on working insulin-producing beta cells in the pancreas, and insulin release tapers when glucose levels are low. The medicine can still cause hypoglycaemia, which may be severe or even life-threatening.
The tablets are used as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Repaglinide is not indicated for use with NPH insulin; serious cardiovascular adverse reactions have been reported with that combination. If a meal is skipped, the scheduled dose should be skipped to reduce the risk of hypoglycaemia.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Repavib 0.5 tablets are used to improve blood sugar control in adults with type 2 diabetes as an addition to diet and exercise. Main uses: adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus; helps lower raised blood glucose in adults with type 2 diabetes when diet and exercise alone are not enough.
Common side effects of Repavib 0.5 Tablet include hypoglycaemia (low blood sugar); upper respiratory infection; headache; sinusitis; joint pain (arthralgia); nausea. Get medical help at once if you notice severe hypoglycaemia, which can cause seizures, may be life-threatening or cause death; serious cardiovascular adverse reactions have been reported when used together with NPH insulin.
Each Repavib 0.5 tablet contains Repaglinide 0.5 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Repavib 0.5 Tablet only as your doctor advises.
The MRP of Repavib 0.5 Tablet is ₹95 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹72.38 and the PTS is ₹65.14.
Each Repavib 0.5 tablet contains Repaglinide 0.5 mg. It comes in a pack of 10x10 (Alu Alu).
Repaglinide 0.5 mg works by prompting the pancreas to release insulin, which helps move glucose from the blood into the body's cells. This action depends on working insulin-producing beta cells in the pancreas, and insulin release tapers when glucose levels are low. The medicine can still cause hypoglycaemia, which may be severe or even life-threatening.
Must not be used in patients with type 1 diabetes mellitus. Must not be used for the treatment of diabetic ketoacidosis. Must not be used together with gemfibrozil. Must not be used in patients with known hypersensitivity to repaglinide or any of its inactive ingredients. Must not be used together with NPH insulin; this combination is not indicated and has been linked to serious cardiovascular adverse reactions.
Repavib 0.5 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner